Natural Alternatives International, Inc. (NASDAQ:NAII)

About the company

Natural Alternatives International, Inc. engages in formulating, manufacturing, and marketing of nutritional supplements. It operates through the following segments: Private-Label Contract Manufacturing, and Patent and Trademark Licensing. The Private Label Contract Manufacturing segment provides manufacturing services to companies that market and distribute nutritional supplements and other health care products. The Patent and Trademark Licensing segment includes royalty income from its license and supply agreements associated with the sale and use of beta-alanine. The company was founded by Mark A. LeDoux in 1980 and is headquartered in Carlsbad, CA.

Sector

Health Technology

Industry

Pharmaceuticals: Other

Employees

186

CEO

Mark A. LeDoux

Exchange

NASDAQ

Website

http://www.nai-online.com

$114.00M

Total Revenue

186

Employees

$49.77M

Market Capitalization

-13.17

Price/Earning ratio

Stock price

Gross Margin (in %)

Total gross margin

$16M

Operating Margin (in %)

Total operating margin

$-4M

Net Margin (in %)

Total net margin

$-4M

Dividend Yield (in %)

Dividend per share

$0

Industry peers

Name Ticker Market capitalization (in USD Million) Revenues (in USD Million) Price/Book Price/Earning Net margin (in %)
Horizon Therapeutics Plc HZNP 12203.10 1376.00 5.20 19.24 43.06
Catalent, Inc. CTLT 10896.37 2872.00 5.47 104.47 3.63
Perrigo Co. Plc PRGO 7574.73 4837.00 1.30 51.67 3.02
Bausch Health Cos., Inc. BHC 6707.00 8597.00 9.36 -3.54 -21.96
Jazz Pharmaceuticals Plc JAZZ 6338.40 2188.00 2.19 23.17 12.81
United Therapeutics Corp. UTHR 5118.72 1443.00 1.78 9.88 36.59
MyoKardia, Inc. MYOK 4243.04 34.00 12.33 -13.69 -201.73
Axsome Therapeutics, Inc. AXSM 2963.17 None 20.11 -32.94 None
Pacira Biosciences, Inc. PCRX 2278.92 435.00 6.11 -5426.00 -0.02
ArQule, Inc. ARQL 2240.00 5.00 15.75 -55.56 -808.06
SAGE Therapeutics, Inc. SAGE 2181.92 9.00 2.56 -3.37 -413.06
Corcept Therapeutics, Inc. CORT 2039.84 335.00 4.68 19.22 31.64
Prestige Consumer Healthcare, Inc. PBH 1850.28 963.00 1.56 13.05 14.77
Revolution Medicines, Inc. RVMD 1738.14 48.00 4.51 -24.55 -146.29
Madrigal Pharmaceuticals, Inc. MDGL 1640.55 0.00 4.38 -16.06 -624.74
Ironwood Pharmaceuticals, Inc. IRWD 1617.89 440.00 -22.90 19.08 19.14
Innoviva, Inc. INVA 1580.87 285.00 3.74 8.18 66.41
Intercept Pharmaceuticals, Inc. ICPT 1475.20 272.00 -43.90 -4.30 -127.53
Portola Pharmaceuticals, Inc. PTLA 1329.78 121.00 19.53 -4.77 -232.73
Zogenix, Inc. ZGNX 1313.55 5.00 3.59 -3.09 -241.62
Supernus Pharmaceuticals, Inc. SUPN 1274.94 402.00 2.02 10.93 28.90
Revance Therapeutics, Inc. RVNC 1230.46 0.00 4.86 -6.59 41.82
Theravance Biopharma, Inc. TBPH 1136.58 88.00 -7.98 -4.61 -280.80
Amphastar Pharmaceuticals, Inc. AMPH 1077.02 327.00 2.69 21.13 15.90
Endo International Plc ENDP 824.22 3014.00 -1.13 -2.94 -9.09
BellRing Brands, Inc. BRBR 771.22 954.00 -0.42 5.85 13.98
Eagle Pharmaceuticals, Inc. EGRX 671.16 192.00 3.61 266.33 1.29
Assembly Biosciences, Inc. ASMB 669.03 16.00 3.00 -6.73 -601.75
Aerie Pharmaceuticals, Inc. AERI 641.70 79.00 5.09 -3.17 -252.92
Collegium Pharmaceutical, Inc. COLL 593.64 299.00 4.25 -45.95 -4.21
Anika Therapeutics, Inc. ANIK 533.82 125.00 1.84 19.26 22.73
Catalyst Pharmaceuticals, Inc. CPRX 524.30 119.00 5.10 11.95 36.09
Intersect ENT, Inc. XENT 445.76 102.00 4.21 -8.93 -48.61
BioDelivery Sciences International, Inc. BDSI 415.84 130.00 5.95 -56.50 -5.01
ANI Pharmaceuticals, Inc. ANIP 376.08 203.00 1.92 -241.08 -0.67
Albireo Pharma, Inc. ALBO 342.42 11.00 3.48 -4.48 -730.55
MEI Pharma, Inc. MEIP 283.86 5.00 4.89 -7.28 -539.48
Mallinckrodt Plc MNK 209.16 3037.00 0.11 -0.17 -39.56
Agile Therapeutics, Inc. AGRX 163.43 None 2.66 -7.91 None
Marinus Pharmaceuticals, Inc. MRNS 161.60 0.00 6.26 -2.40 None
Cerecor, Inc. CERC 119.60 7.00 7.65 -5.31 -429.22
Ampio Pharmaceuticals, Inc. AMPE 98.67 1.00 69.00 -5.31 None
Evoke Pharma, Inc. EVOK 89.28 None 31.00 -13.29 None
AcelRx Pharmaceuticals, Inc. ACRX 84.80 2.00 -1.56 -1.51 -644.25
Zynerba Pharmaceuticals, Inc. ZYNE 80.50 0.00 1.32 -2.24 -699.94
Adamas Pharmaceuticals, Inc. ADMS 71.68 57.00 -4.57 -0.77 -160.44
CTI BioPharma Corp. CTIC 70.21 3.00 3.13 -1.70 -111.83
Aclaris Therapeutics, Inc. ACRS 68.88 4.00 1.21 -0.50 None
Oramed Pharmaceuticals, Inc. ORMP 60.30 3.00 4.86 -4.72 -464.15
Cassava Sciences, Inc. SAVA 56.43 41.00 2.97 -12.38 76.71
Natural Alternatives International, Inc. NAII 49.77 114.00 0.68 -13.17 -3.19
SCYNEXIS, Inc. SCYX 48.89 0.00 10.27 -1.26 -30.84
Cumberland Pharmaceuticals, Inc. CPIX 48.60 47.00 0.99 -10.80 -9.59
Lipocine, Inc. LPCN 43.50 0.00 10.36 -2.90 None
IsoRay, Inc. ISR 38.19 9.00 7.12 -11.40 -36.08
Acasti Pharma, Inc. ACST 35.84 827.00 2.33 -0.58 -7.45
Neos Therapeutics, Inc. NEOS 35.45 65.00 -2.73 -2.03 -26.74
PLx Pharma, Inc. PLXP 27.18 0.00 -2.60 -2.88 119.04
CytRx Corp. CYTR 22.11 0.00 1.60 -3.19 408.46
EyeGate Pharmaceuticals, Inc. EYEG 19.24 3.00 2.39 -1.62 -264.21
Regulus Therapeutics, Inc. RGLS 18.15 0.00 1.60 -0.85 -272.13
Tetraphase Pharmaceuticals, Inc. TTPH 12.30 8.00 0.65 -0.15 -798.18
Intec Pharma Ltd. NTEC 10.66 None 1.37 -0.25 None
VIVUS, Inc. VVUS 8.69 73.00 -0.19 -0.29 -39.28
Sonoma Pharmaceuticals, Inc. SNOA 6.46 19.00 1.02 -2.07 -25.58
KemPharm, Inc. KMPH 6.02 15.00 -0.17 -0.35 -120.48
Hepion Pharmaceuticals, Inc. HEPA 5.76 None 1.80 -0.48 None
Tonix Pharmaceuticals Holding Corp. TNXP 4.20 None 1.05 -0.09 None
Ritter Pharmaceuticals, Inc. RTTR 0.45 None 0.17 -0.03 None

Latest insider transactions

Date Role Name Transaction Quantity Quantity Owned After

Natural Alternatives International, Inc. Announces 2020 Q3 and YTD Results

1mon ago, source: WFMZ-TV

NATURAL ALTERNATIVES INTERNATIONAL, INC. CONDENSED CONSOLIDATED STATEMENTS OF INCOME (In thousands, except per share data) (Unaudited) Three Months Ended Nine Months Ended March 31, March 31, 2020 ...

Natural Alternatives International Inc.

27d ago, source: MarketWatch

02/12/2016 1,200 Disposition at $10.14 per share. 12,168 ...

NAII Natural Alternatives International, Inc. Common Stock

27d ago, source: Nasdaq

Sign up for our newsletter to get the latest on the transformative forces shaping the global economy, delivered every Thursday.

StemSation International, Inc.: Stemsation Expands Product Line With Stemflex Enters the Fast-Growing $9 Billion CBD Market

8d ago, source: Finanznachrichten

BOCA RATON, FL / ACCESSWIRE / June 28, 2020 / StemSation International, Inc. (OTC Pink:STSN) - a pioneer in the emerging category of dietary supplements called Stem Cell Nutrition, announces its third ...

Natural Alternatives International, Inc.

2mon ago, source: Reuters

May 14 (Reuters) - Natural Alternatives International Inc <NAII.O>::NATURAL ALTERNATIVES INTERNATIONAL, INC. ANNOUNCES 2020 Q3 AND YTD RESULTS.Q3 LOSS PER SHARE $0.61.QTRLY NET SALES $25.5 MILLION ...

Natural Alternatives International, Inc. Announces 2020 Q2 and YTD Results

1mon ago, source: Bloomberg

Before it's here, it's on the Bloomberg Terminal.

Natural Alternatives International Inc

20d ago, source: Bloomberg

When autocomplete results are available use up and down arrows to review and enter to select. Touch device users, explore by touch or with swipe gestures.



Portfolio items

Follow companies to create your optimal portfolio.
or
Refresh this page to see your newly added stocks.